Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3780 |  SEER Seer, Inc. - Class A Common Stock | 2.17 USD | -1.81% | -3.56% | +11.86% | -6.47% | 120.16 M USD | ||
| 3785 |  ENGN enGene Therapeutics Inc. - Common Stock | 1.78 USD | +1.71% | -11.00% | -5.82% | -78.81% | 119.29 M USD | ||
| 3786 |  VTVT vTv Therapeutics Inc. - Class A Common Stock | 30.08 USD | -3.00% | -6.58% | -8.82% | +46.73% | 118.94 M USD | ||
| 3791 |  FHTX Foghorn Therapeutics Inc. - Common Stock | 1.99 USD | -4.78% | -28.93% | -58.46% | -51.23% | 118.18 M USD | ||
| 3795 |  COYA Coya Therapeutics, Inc. - Common Stock | 4.99 USD | +1.63% | +3.96% | +8.24% | -20.29% | 117.05 M USD | ||
| 3811 |  UNCY Unicycive Therapeutics, Inc. - Common Stock | 4.07 USD | -2.63% | -11.90% | -19.25% | -37.48% | 113.37 M USD | ||
| 3815 |  GNLX Genelux Corporation - Common Stock | 2.50 USD | -0.79% | -1.96% | -1.96% | -54.46% | 113.11 M USD | ||
| 3819 |  INO Inovio Pharmaceuticals, Inc. - Common Stock | 1.09 USD | -6.03% | -11.38% | -17.42% | -58.24% | 112.70 M USD | ||
| 3824 |  VANI Vivani Medical, Inc. - Common Stock | 1.23 USD | -3.15% | -0.81% | -6.11% | -12.14% | 110.95 M USD | ||
| 3825 |  LENZ LENZ Therapeutics, Inc. - Common Stock | 3.53 USD | -2.49% | -8.07% | -33.52% | -89.14% | 110.91 M USD | ||
| 3827 |  IFRX InflaRx N.V. - Common Stock | 1.53 USD | -1.92% | -12.07% | -25.37% | +5.52% | 110.61 M USD | ||
| 3828 |  RANI Rani Therapeutics Holdings, Inc. - Class A Common Stock | 0.79 USD | -2.47% | -2.47% | -7.06% | +64.58% | 110.12 M USD | ||
| 3845 |  BDTX Black Diamond Therapeutics, Inc. - Common Stock | 1.81 USD | -1.09% | -5.24% | -12.14% | -58.58% | 103.99 M USD | ||
| 3849 |  IMUX Immunic, Inc. - Common Stock | 7.56 USD | -0.92% | -13.10% | -37.26% | +721.74% | 103.15 M USD | ||
| 3850 |  AARD Aardvark Therapeutics, Inc. - Common Stock | 4.71 USD | -5.04% | -12.29% | -11.63% | -62.65% | 103.08 M USD | ||
| 3856 |  CRBP Corbus Pharmaceuticals Holdings, Inc. - Common Stock | 5.27 USD | -4.01% | -19.66% | -50.28% | -68.25% | 101.93 M USD | ||
| 3858 |  ANIX Anixa Biosciences, Inc. - Common Stock | 2.91 USD | -1.36% | +2.83% | +5.43% | -41.09% | 101.16 M USD | ||
| 3866 |  BMEA Biomea Fusion, Inc. - Common Stock | 1.37 USD | +3.79% | +7.03% | -25.14% | -22.16% | 99.30 M USD | ||
| 3890 |  ATRA Atara Biotherapeutics, Inc. - Common Stock | 9.23 USD | -1.49% | +11.88% | -10.13% | -37.42% | 92.65 M USD | ||
| 3897 |  EQ Equillium, Inc. - Common Stock | 1.44 USD | +3.60% | -7.10% | -43.31% | 0.00% | 91.31 M USD |
Notícias Biotechnology Stocks
Estudo da Lancet mostra alívio mais rápido com remédio da Pharvaris para AEH
Raymond James inicia cobertura da Kymera Therapeutics com recomendação acima da média
Raymond James inicia cobertura da Nektar com classificação de desempenho de mercado
Ação da Palisade Bio inicia cobertura com Outperform na Raymond James
Raymond James mantém recomendação para ações da Liquidia em meio a processos judiciais
Ginkgo Bioworks vai apoiar o programa NSF X-Labs com acesso a laboratório
AbCellera apresentará dados de fase 1/2 sobre candidato a medicamento para menopausa
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |